UK markets closed

Ion Beam Applications SA (IOBCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
19.270.00 (0.00%)
At close: 03:23PM EST
Full screen
Trade prices are not sourced from all markets
Previous close19.27
Open19.27
Bid0.00 x 0
Ask0.00 x 0
Day's range19.27 - 19.27
52-week range11.13 - 20.95
Volume240
Avg. volume201
Market cap561.911M
Beta (5Y monthly)0.77
PE ratio (TTM)120.47
EPS (TTM)0.16
Earnings dateN/A
Forward dividend & yield0.20 (1.07%)
Ex-dividend date29 Jun 2022
1y target estN/A
  • Globe Newswire

    IBA - Regulated Information

    IBA SA – Regulated information January 25th, 2023 Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various provisions (Belgian Gazette 12.VI.2007 ) (hereinafter, the “Law”) Under this provision: "[...] the issuer publishes the total capital, the total number of securities conferring the right to vote and voting rights, as well as, by category, the number of

  • Globe Newswire

    IBA announces contract with Moffitt Cancer Center for a Proteus®ONE proton therapy solution in Florida, US

    Louvain-La-Neuve, Belgium, 10 January 2023 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces that it has received the downpayment for a contract signed at the end of December 2022 with the H. Lee Moffitt Cancer Center and Research Institute Hospital (“Moffitt”) in Tampa, Florida, US, for the installation of its Proteus®ONE1 compact proton therapy system. As Florida’s only National Cancer Institute-designated comprehensive cancer ce

  • Globe Newswire

    IBA signs contract to install a fully integrated X-ray irradiation solution in France

    Significant contract win for IBA’s Industrial Solutions; first time the division has sold a complete irradiation solution Louvain-La-Neuve, Belgium, 22 December 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announced that it has signed a contract to install a fully integrated X-ray irradiation solution at a customer’s new service center site in France. The solution includes an IBA Rhodotron®, a Beagle® process control system, a safe